These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Kaposi's sarcoma in patients with human immunodeficiency virus infection in Taiwan. Lin CY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Lo YC; Hung CC; Chang SC J Microbiol Immunol Infect; 2009 Jun; 42(3):227-33. PubMed ID: 19812856 [TBL] [Abstract][Full Text] [Related]
4. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy. Antinori A; Larussa D; Cingolani A; Lorenzini P; Bossolasco S; Finazzi MG; Bongiovanni M; Guaraldi G; Grisetti S; Vigo B; Gigli B; Mariano A; Dalle Nogare ER; De Marco M; Moretti F; Corsi P; Abrescia N; Rellecati P; Castagna A; Mussini C; Ammassari A; Cinque P; d'Arminio Monforte A; Clin Infect Dis; 2004 Dec; 39(11):1681-91. PubMed ID: 15578371 [TBL] [Abstract][Full Text] [Related]
5. Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy. Bertschy S; Opravil M; Cavassini M; Bernasconi E; Schiffer V; Schmid P; Flepp M; Chave JP; Christen A; Furrer H; Clin Microbiol Infect; 2006 Jul; 12(7):666-71. PubMed ID: 16774564 [TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital. Liang SH; Lo YC; Lin HH; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC J Microbiol Immunol Infect; 2008 Jun; 41(3):200-8. PubMed ID: 18629414 [TBL] [Abstract][Full Text] [Related]
7. Toxoplasmosis in HIV/AIDS patients: a current situation. Nissapatorn V; Lee C; Quek KF; Leong CL; Mahmud R; Abdullah KA Jpn J Infect Dis; 2004 Aug; 57(4):160-5. PubMed ID: 15329448 [TBL] [Abstract][Full Text] [Related]
8. Clinical and diagnostic management of toxoplasmosis in the immunocompromised patient. Contini C Parassitologia; 2008 Jun; 50(1-2):45-50. PubMed ID: 18693556 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for toxoplasmic encephalitis in HIV-infected patients: a case-control study in Brazil. Nascimento LV; Stollar F; Tavares LB; Cavasini CE; Maia IL; Cordeiro JA; Ferreira MU Ann Trop Med Parasitol; 2001 Sep; 95(6):587-93. PubMed ID: 11672464 [TBL] [Abstract][Full Text] [Related]
10. Evolving characteristics of toxoplasmosis in patients infected with human immunodeficiency virus-1: clinical course and Toxoplasma gondii-specific immune responses. Hoffmann C; Ernst M; Meyer P; Wolf E; Rosenkranz T; Plettenberg A; Stoehr A; Horst HA; Marienfeld K; Lange C Clin Microbiol Infect; 2007 May; 13(5):510-5. PubMed ID: 17298486 [TBL] [Abstract][Full Text] [Related]
11. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy. Sheng WH; Hung CC; Wu RJ; Wang JT; Chen PJ; Chang SC; Kao JH Clin Infect Dis; 2007 Feb; 44(4):584-90. PubMed ID: 17243064 [TBL] [Abstract][Full Text] [Related]
12. [Visceral leishmaniasis: a comparative study of patients with and without human immunodeficiency virus infection]. Reus S; Sánchez R; Portilla J; Boix V; Priego M; Merino E; Román F Enferm Infecc Microbiol Clin; 1999 Dec; 17(10):515-20. PubMed ID: 10650648 [TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era. Abgrall S; Rabaud C; Costagliola D; Clin Infect Dis; 2001 Nov; 33(10):1747-55. PubMed ID: 11595976 [TBL] [Abstract][Full Text] [Related]
14. Toxoplasma encephalitis in an HIV-infected patient on highly active antiretroviral therapy despite sustained immune response. Atreya AR; Arora S; Gadiraju VT; Martagon-Villamil J; Skiest DJ Int J STD AIDS; 2014 Apr; 25(5):383-6. PubMed ID: 24108450 [TBL] [Abstract][Full Text] [Related]
15. Clinical experience of HIV/AIDS in a municipal hospital in Taiwan. Wu YL; Chang CC; Chang HC; Yang CH; Liao ST Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 May; 30(2):84-95. PubMed ID: 10592814 [TBL] [Abstract][Full Text] [Related]
16. Toxoplasmosis of the central nervous system in patients with AIDS in Mexico. del Rio-Chiriboga C; Orzechowski-Rallo A; Sanchez-Mejorada G Arch Med Res; 1997; 28(4):527-30. PubMed ID: 9428578 [TBL] [Abstract][Full Text] [Related]
17. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention. Anekthananon T; Ratanasuwan W; Techasathit W; Rongrungruang Y; Suwanagool S J Med Assoc Thai; 2004 Feb; 87(2):173-9. PubMed ID: 15061301 [TBL] [Abstract][Full Text] [Related]
18. Characteristics of HIV-infected tuberculosis patients in Thailand. Mankatittham W; Likanonsakul S; Thawornwan U; Kongsanan P; Kittikraisak W; Burapat C; Akksilp S; Sattayawuthipong W; Srinak C; Nateniyom S; Tasaneeyapan T; Varma JK Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):93-103. PubMed ID: 19323040 [TBL] [Abstract][Full Text] [Related]
19. Clinical presentation and outcome of toxoplasma encephalitis in HIV-infected patients from Zaria, Northern Nigeria: a case series of 9 patients. Ogoina D; Obiako RO; Onyemelukwe GC; Musa BO; Hamidu AU J Int Assoc Provid AIDS Care; 2014; 13(1):18-21. PubMed ID: 23962913 [TBL] [Abstract][Full Text] [Related]
20. Central nervous system toxoplasmosis in adult Ethiopians. Amogne W; Teshager G; Zenebe G Ethiop Med J; 2006 Apr; 44(2):113-20. PubMed ID: 17447372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]